Search

Priced at €2.35 per share, representing a 15.44% discount on the 5-day VWAP

Oryzon secures new patents in Europe and Japan for vafidemstat, extending protection until 2040 for ADHD and autism spectrum disorder.

Oryzon Genomics has launched a clinical trial in the U.S. to evaluate for the first time the combination of its epigenetic inhibitor iadademstat with immunotherapy in patients with metastatic small

Meet our new member Schrödinger. We sponke with María José Aliaga, Associate Account Manager.

The convertible note is a financing instrument that initially functions as a loan and is subsequently converted into a shareholding.

Meet our new member NoctuRNA. We spoke with a Miriam Corredor , CEO.

The report highlights critical vulnerabilities within pharmaceutical supply chains in Europe and proposes substantial investment in strategic projects, procurement policies, and a harmonized and

TECNALIA promotes projects such as INNOPROTEIN, which focus on developing new sources of proteins and functional compounds from agri-food by-products. These advances address sector challenges and the

Premature mortality from cirrhosis in Spain had an economic impact of over €2.4 billion in 2021, according to BCN HEALTH. The study, published in Current Medical Research and Opinion, highlights the

AseBio will closely monitor developments and analyze the implications that the tariffs imposed by the United States may have on the biotechnology sector, which is crucial for the strategic autonomy of

Natac's Omega 3 division has partnered with the best suppliers to produce in its As Somozas factory this 18 EPA/12 DHA oil.

It was funded by Spanish Ministry of Science, Innovation and Universities (MCIN) and the European Union through the NextGeneration EU programme.

It is the most common form of juvenile macular degeneration, leading to progressive central vision loss and ultimately resulting in blindness, with no approved treatments available.

Meet our new member Biomol. We spoke with a Cristina Moreno Periáñez , Marketing Director.

In recent years, Spain has experienced extraordinary growth in the biotechnology sector, consolidating itself as a key area for innovation, research, and economic development.